Nab-paclitaxel in the treatment of breast cancer: clinical trial data and first-hand experience

by E. I. Borisova, S. P. Gutorov, G. V. Vyshinskaya, N. V. Dobrova, M. E. Abramov
Published 2018-11-01

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

by Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Yoshihito Tanaka, Masamichi Itoga, Kunihiko Nakamura, Akihito Hayashi, Mika Kumagai, Hideo Yasugahira, Megumi Mikuniya, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Published 2017-10-01

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

by I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin
Published 2019-12-01

Albumin-bound paclitaxel in the treatment of metastatic breast cancer

by E V Artamonova
Published 2017-01-01

Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel: Two Case Reports

by Tomoyuki Araya, Toshiyuki Kita, Hiroki Matsuoka, Tamami Sakai, Hideharu Kimura, Kazuo Kasahara
Published 2020-12-01

The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer

by M A Frolova
Published 2016-09-01

Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report

by Sumit Gaur, Alireza Torabi, Thomas J O'Neill
Published 2012-06-01

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

by Ursula M. Vogl, Haleh Andalibi, Alexander Klaus, Laurenz Vormittag, Wolfgang Schima, Bettina Heinrich, Alice Kafka, Thomas Winkler, Leopold Öhler
Published 2019-01-01

Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use

by Elena Ferris Villanueva, Mónica Martínez Penella, Pablo Cerezuela Fuentes, Rocío Guerrero Bautista, Andrés García Márquez, María Del Carmen Mira Sirvent
Published 2015-02-01

nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma

by Go Makimoto, Keiichi Fujiwara, Hiromi Watanabe, Nobuhisa Kameyama, Mizuho Matsushita, Kammei Rai, Ken Sato, Toshiro Yonei, Toshio Sato, Takuo Shibayama
Published 2014-01-01

Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

by Sara Pusceddu, Michele Ghidini, Martina Torchio, Francesca Corti, Gianluca Tomasello, Monica Niger, Natalie Prinzi, Federico Nichetti, Andrea Coinu, Maria Di Bartolomeo, Mary Cabiddu, Rodolfo Passalacqua, Filippo de Braud, Fausto Petrelli
Published 2019-04-01

Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer

by Vineet Talwar, Shubhra Raina, Varun Goel, Prasanta Dash, Dinesh C Doval
Published 2020-01-01

Nab-paclitaxel monotherapy in patients with metastatic breast cancer with visceral crisis: evaluation of efficacy and tolerability in clinical practice

by L. Yu. Vladimirova, K. A. Novoselova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, L. A. Ryadinskaya, A. A. Lyanova, M. O. Ezhova, M. A. Teplyakova, A. A. Tishina, E. V. Prikhodko
Published 2019-06-01

The prospects for cisplatin and nab-paclitaxel combination therapy in patients with pre-treated triple-negative breast cancer. Description of the clinical case.

by L. G. Zhukova, K. S. Bardovskaya, E. V. Lubennikova, I. R. Suslova
Published 2018-07-01

The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids

by Xiao X, Chen W, Wei ZW, Chu WW, Lu XF, Li B, Chen H, Meng SJ, Hao TF, Wei JT, He YL, Zhang CH
Published 2020-06-01

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric c...

by Yasuyuki Kawamoto, Yoshito Komatsu, Satoshi Yuki, Kentaro Sawada, Tetsuhito Muranaka, Kazuaki Harada, Hiroshi Nakatsumi, Hiraku Fukushima, Atsushi Ishiguro, Masayoshi Dazai, Kazuteru Hatanaka, Michio Nakamura, Ichiro Iwanaga, Minoru Uebayashi, Susumu Sogabe, Yoshimitsu Kobayashi, Takuto Miyagishima, Kota Ono, Naoya Sakamoto, Yuh Sakata
Published 2017-12-01

Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilo...

by Wang D, Zhang W, Qian D, Guan Y, Chen X, Zhang H, Wang J, Pang Q
Published 2018-09-01

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer

by Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios Theocharis, Pavlos Papakotoulas, Dimitrios Schizas, Alexandros Papalampros, Evangelos Felekouras, Athanasios G. Papavassiliou, Michalis V. Karamouzis
Published 2021-06-01

COMBINATION CHEMOTHERAPY REGIMENS IN PANCREATIC CANCER

by A. S. POPOVA, I. A. POKATAEV, S. A. TYULYANDIN
Published 2017-06-01

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to f...

by Kenro Hirata, Yasuo Hamamoto, Masahiko Ando, Chiyo K. Imamura, Kenichi Yoshimura, Kentaro Yamazaki, Shuichi Hironaka, Kei Muro
Published 2020-06-01